The Efficacy of a Single Dose of Intranasal Oxytocin in the Prevention of Post Traumatic Stress Disorder (PTSD)
Status:
Unknown status
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
This study is designed to test the hypothesis that a single administration of intranasal
oxytocin within 6 hours post-trauma facilitates the physiological recovery for the trauma,
thereby preventing the development of Post Traumatic Stress Disorder (PTSD) in the months
following the event. In the absence of such treatment (i.e., under placebo conditions), we
hypothesize that a greater proportion of persons will develop PTSD (i.e., fail to recover
from acute effects).